SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Visible Genetics Inc.(VGIN) -- Ignore unavailable to you. Want to Upgrade?


To: Steve Lokness who wrote (182)4/18/1998 9:06:00 PM
From: Richard Haugland  Read Replies (2) | Respond to of 337
 
If rumor shot the stock up earlier this seek the rumor has mostly died. I look for an optimistic quarterly report by VGINF, even if it is not yet profitable. Presumably we will see a good rise in revenues from instrument sales and kits. The company seemed to make some positive gains in establishing itself this past quarter and the deal with Amersham will hopefully lead to some real revenues in the near term.

The key to the company's success will be approvals for its tests under development.